KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 104 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,043,937 | -43.0% | 60,100 | -53.8% | 0.00% | -50.0% |
| Q2 2023 | $1,831,808 | +118.0% | 130,100 | +66.6% | 0.00% | +100.0% |
| Q1 2023 | $840,119 | +335.3% | 78,078 | +420.5% | 0.00% | – |
| Q3 2022 | $193,000 | +17.7% | 15,000 | -11.8% | 0.00% | – |
| Q2 2022 | $164,000 | -74.8% | 17,000 | -63.6% | 0.00% | – |
| Q2 2021 | $650,000 | -3.1% | 46,686 | +28.7% | 0.00% | – |
| Q1 2021 | $671,000 | – | 36,277 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |